A 54-year-old woman with newly diagnosed type 2 diabetes (HbA1c 8.0% [64 mmol/mol]) and BMI 33 kg/m² has no significant comorbidities and eGFR 80 mL/min/1.73 m². According to current Australian diabetes guidelines, what is the most appropriate initial pharmacological management in addition to lifestyle modification?